ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.53
+0.35 (5.60%)
Sep 3, 2025, 4:00 PM - Market closed
ImmuCell Market Cap
ImmuCell has a market cap or net worth of $59.03 million as of September 3, 2025. Its market cap has increased by 104.24% in one year.
Market Cap
59.03M
Enterprise Value
66.55M
1-Year Change
104.24%
Ranking
Category
Stock Price
$6.53
Market Cap Chart
Since May 1, 1992, ImmuCell's market cap has increased from $1.99M to $59.03M, an increase of 2,863.52%. That is a compound annual growth rate of 10.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 55.90M | 21.81% |
| Dec 31, 2024 | 45.89M | 16.33% |
| Dec 29, 2023 | 39.45M | -16.51% |
| Dec 30, 2022 | 47.26M | -23.70% |
| Dec 31, 2021 | 61.94M | 44.32% |
| Dec 31, 2020 | 42.92M | 15.59% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.66B |
| Johnson & Johnson | 426.69B |
| AbbVie | 371.68B |
| UnitedHealth Group | 280.64B |
| Novo Nordisk | 254.41B |
| AstraZeneca | 248.96B |
| Novartis AG | 245.38B |
| Abbott Laboratories | 230.89B |